BioAv Cancer Research Results
BioAv, bioavailability: Click to Expand ⟱
| Source: |
| Type: measurement |
Bioavailability (usually in %) absorbed by the body.
|
Scientific Papers found: Click to Expand⟱
*Inflam↓, AntiCan↑, BioAv↝, BioAv⇅, BioAv↓, CYP3A2↓, P-gp/ABCB1↓,
*Dose↝, *Dose?, *other?, BioAv⇅,
Showing Research Papers: 1 to 2 of 2
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 2
Pathway results for Effect on Cancer / Diseased Cells:
Drug Metabolism & Resistance(tgid=21) ⓘ
BioAv↓, 1, BioAv⇅, 2, BioAv↝, 1, CYP3A2↓, 1, P-gp/ABCB1↓, 1,
Functional Outcomes(tgid=23) ⓘ
AntiCan↑, 1,
Total Targets: 6
Pathway results for Effect on Normal Cells:
Transcription & Epigenetics(tgid=7) ⓘ
other?, 1,
Immune & Inflammatory Signaling(tgid=16) ⓘ
Inflam↓, 1,
Drug Metabolism & Resistance(tgid=21) ⓘ
Dose?, 1, Dose↝, 1,
Total Targets: 4
Scientific Paper Hit Count for: BioAv, bioavailability
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:0 prod#:% Target#:792 State#:% Dir#:3
wNotes=0 sortOrder:rid,rpid
Home Page